Weather

86°F9:39 PM

Health

1 read

New Research Suggests Weight Loss Drugs May Aid Addiction Treatment

KVIA•Thursday, March 5, 2026 at 7:57 PM•CNN Newsource

Medical stethoscope representing healthcare news

Want the full story?

Read the complete article at KVIA

AI Summary

Recent studies indicate that popular weight loss medications known as GLP-1, including Ozempic and Wegovy, may also be effective in treating addiction. These drugs, which are already used by millions for diabetes and obesity, influence appetite and cravings, potentially offering new hope for addiction therapy. Research from Washington University analyzed over 600,000 diabetes patients and found that those on GLP-1 medications had a lower incidence of substance use disorders. As clinical trials are underway, results are expected within six months, which could significantly impact addiction treatment protocols. The findings highlight a possible 50% reduction in drug-related deaths among users, emphasizing the potential of these medications beyond their original purpose.

Key Details: • Results from new studies on GLP-1 drugs expected in the next six months. • Research analyzed data from over 600,000 diabetes patients. • GLP-1 medications may reduce the risk of substance use disorders. • Potential 50% reduction in drug-related deaths observed. • Current use of GLP-1 drugs is widespread among millions.

health research medications addiction substance-abuse

People & Organizations

Centers for Disease Control and PreventionDr. W. Kyle SimmonsDr. Daniel DruckerDr. Ziyad Al-AlyDr. Christian HendershotWashington University School of MedicineOklahoma State UniversityUSC Institute for Addiction Science

Related Articles

Eczema Treatment Cream Recalled Due to Serious Infection Risk

A recall has been issued for the Multi-symptom Treatment Cream & Skin Protectant Eczema Cream, marketed as MG217, after contamination with Staphylococcus aureus was detected. This bacteria poses a significant risk of life-threatening infections, prompting the Food and Drug Administration (FDA) to take action. Consumers using this product should be aware of the potential health hazards associated with it. The recall affects a specific batch of the cream, and users are advised to discontinue its use immediately and consult healthcare professionals if they experience any adverse effects.

Eczema Cream Recall Due to Contamination Risk for El Paso Residents

A recall has been issued for the MG217 Multi-symptom Treatment Cream & Skin Protectant Eczema Cream, produced by Pharmacal, after it was discovered to be contaminated with Staphylococcus aureus, a bacteria that can cause severe infections. The FDA announced the recall on Tuesday, highlighting the potential risk of life-threatening staph infections associated with the use of this product. Consumers in El Paso who have purchased this cream should check their medicine cabinets and discontinue use immediately. The recall underscores the importance of monitoring health products for safety concerns.

Cruise Passenger in Nebraska Biocontainment Unit Amid Hantavirus Outbreak

Dr. Stephen Kornfeld, a passenger on the MV Hondius cruise, is currently isolated in a biocontainment unit at the University of Nebraska Medical Center after testing positive for Andes hantavirus. His situation follows an outbreak on the ship, which has resulted in three deaths and several confirmed cases among passengers and crew. As of now, 122 individuals have been evacuated, with ongoing monitoring of 17 Americans and one British dual-national for symptoms. The World Health Organization has confirmed 11 cases related to the cruise, emphasizing that the risk to the general public remains low. Passengers are facing weeks of isolation as health officials conduct assessments and interviews to track the virus's spread.

Argentine Traveler Shares Experience on Hantavirus-Stricken Cruise

Carlos Ferello, an Argentine retiree, was the sole representative from his country aboard the MV Hondius, a cruise ship that recently experienced a hantavirus outbreak, leading to several confirmed cases and three fatalities. After the ship docked in the Canary Islands, Ferello was evacuated and is now in isolation for at least 42 days in Amsterdam. The outbreak began with symptoms in a Dutch passenger, resulting in a tragic chain of events that highlighted the challenges of managing health crises on closed vessels. As of now, nine cases have been confirmed, prompting strict safety measures similar to those during the COVID-19 pandemic, including mask-wearing and social distancing on board. Ferello's story sheds light on the human experience amid a health scare and the resilience of those affected.